Blinded Pain Cocktails: A Reliable and Safe Opioid Weaning Method

Anesthesiol Clin. 2023 Jun;41(2):371-381. doi: 10.1016/j.anclin.2023.03.006. Epub 2023 Apr 14.

Abstract

Weaning opioids in patients with noncancerous chronic pain often poses a challenge when psychosocial factors complicate the patient's chronic pain syndrome and opioid use. A blinded pain cocktail protocol used to wean opioid therapy has been described since the 1970s. At the Stanford Comprehensive Interdisciplinary Pain Program, a blinded pain cocktail remains a reliably effective medication-behavioral intervention. This review (1) outlines psychosocial factors that may complicate opioid weaning, (2) describes clinical goals and how to use blinded pain cocktails in opioid tapering, and (3) summarizes the mechanism of dose-extending placebos and ethical justification of its use in clinical practice.

Keywords: Blinded pain cocktail; Dose-extending placebo; Methadone; Opioid weaning.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Chronic Pain* / drug therapy
  • Humans
  • Opioid-Related Disorders* / drug therapy

Substances

  • Analgesics, Opioid